Works matching IS 25785745 AND DT 2023 AND VI 5 AND IP 3


Results: 9
    1
    2
    3
    4
    5
    6

    Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo‐Controlled DISCOVER‐1 Study

    Published in:
    ACR Open Rheumatology, 2023, v. 5, n. 3, p. 149, doi. 10.1002/acr2.11523
    By:
    • Ritchlin, Christopher T.;
    • Deodhar, Atul;
    • Boehncke, Wolf‐Henning;
    • Soriano, Enrique R.;
    • Kollmeier, Alexa P.;
    • Xu, Xie L.;
    • Zazzetti, Federico;
    • Shawi, May;
    • Jiang, Yusang;
    • Sheng, Shihong;
    • Helliwell, Philip S.
    Publication type:
    Article
    7
    8
    9

    Issue Information.

    Published in:
    ACR Open Rheumatology, 2023, v. 5, n. 3, p. 103, doi. 10.1002/acr2.11455
    Publication type:
    Article